troglitazone has been researched along with fluorodeoxyglucose f18 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, Y; Momose, T; Moritan, T; Nagai, R; Ohtomo, K; Tateno, M; Yokoyama, I; Yonekura, K | 1 |
| Cho, YS; Jung, KH; Lee, JH; Lee, KH; Lee, SJ; Moon, SH; Park, JW; Quach, CH | 1 |
2 other study(ies) available for troglitazone and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Troglitazone improves whole-body insulin resistance and skeletal muscle glucose use in type II diabetic patients.
Topics: Blood Glucose; Chromans; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Fluorodeoxyglucose F18; Glucose; Humans; Hypertension; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Middle Aged; Muscle, Skeletal; Radiopharmaceuticals; Thiazoles; Thiazolidinediones; Tomography, Emission-Computed; Troglitazone | 2001 |
Troglitazone Stimulates Cancer Cell Uptake of 18F-FDG by Suppressing Mitochondrial Respiration and Augments Sensitivity to Glucose Restriction.
Topics: Antineoplastic Agents; Biological Transport; Cell Respiration; Chromans; Dose-Response Relationship, Drug; Fluorodeoxyglucose F18; Glucose; Glycolysis; HCT116 Cells; Humans; MAP Kinase Signaling System; Matrix Metalloproteinases; Mitochondria; Oxygen; PPAR gamma; Reactive Oxygen Species; Thiazolidinediones; Troglitazone | 2016 |